Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
---|
07/02/2013 | US8476446 Isoxazole derivatives for use as fungicides |
07/02/2013 | US8476434 Protein kinase modulators and method of use |
07/02/2013 | US8476298 c-Met modulators and method of use |
07/02/2013 | US8476278 Thiazole Derivatives as protein kinase inhibitors |
07/02/2013 | US8476274 Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators |
07/02/2013 | US8476269 Pyridine and pyrazine derivative for the treatment of CF |
07/02/2013 | US8476264 N-(3-(2-amino-6,6-difluoro-4,4A,5,6,7,7A-hexahydro-cyclopenta[E][1,3]oxazin-4-yl)-phenylamides as BACE1 inhibitors |
07/02/2013 | US8476262 Cyanopyrroles |
07/02/2013 | US8476257 Viral polymerase inhibitors |
07/02/2013 | CA2737694C Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
07/02/2013 | CA2657469C Novel aminopyridine derivatives having aurora a selective inhibitory action |
07/02/2013 | CA2599879C Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
06/27/2013 | WO2013096971A1 Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalyst |
06/27/2013 | WO2013096226A1 Trpv1 antagonists |
06/27/2013 | WO2013096060A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
06/27/2013 | WO2013096051A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
06/27/2013 | WO2013096049A1 Compounds for inhibiting the interaction of bcl2 with binding partners |
06/27/2013 | WO2013095275A1 Novel hepatitis c virus inhibitors |
06/27/2013 | WO2013093940A1 Nitrofurfuryl substituted phenyl linked piperidino-oxadiazoline conjugates as anti-tubercular agents and process for the preparation thereof |
06/27/2013 | WO2013093850A1 Quinoline derivatives |
06/27/2013 | WO2013093849A1 Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives |
06/27/2013 | WO2013093842A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
06/27/2013 | WO2013092976A1 New piperidine derivatives, pharmaceutical compositions and uses thereof |
06/27/2013 | WO2013092939A1 BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS |
06/27/2013 | WO2013092893A1 Chemical compounds |
06/27/2013 | WO2013092859A1 Process for manufacturing 4-substituted amino-benzoxazinones |
06/27/2013 | WO2013092858A1 Process for manufacturing triazinon-benzoxazinones |
06/27/2013 | WO2013092856A1 Process for manufacturing benzoxazinones |
06/27/2013 | WO2013092850A1 Process for manufacturing aryloxyacetamides |
06/27/2013 | WO2013092711A1 Trpm8 antagonists |
06/27/2013 | WO2013092616A1 New aziridine compounds, pharmaceutical compositions and their use as acetyl-coa carboxylase inhibitors |
06/27/2013 | WO2013091011A1 Heterocyclic urea compounds |
06/27/2013 | US20130165490 Insecticidal compounds |
06/27/2013 | US20130165485 Insecticidal compounds |
06/27/2013 | US20130165452 Substituted Heteroaryls |
06/27/2013 | US20130165444 Piperidine Derivatives |
06/27/2013 | US20130165441 Novel Polymorphs and Salts |
06/27/2013 | US20130165440 JAK1 Inhibitors |
06/27/2013 | US20130165436 Dihydro-Benzo-Oxazine and Dihydro-Pyrido-Oxazine Derivatives |
06/27/2013 | US20130165433 Novel Use |
06/27/2013 | US20130165432 Dual Modulators of 5HT2A and D3 Receptors |
06/27/2013 | US20130165431 Inhibitors of syk and jak protein kinases |
06/27/2013 | US20130165422 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
06/27/2013 | US20130165412 Cannabinoid receptor modulators |
06/27/2013 | US20130164259 1,4-substituted piperazine derivatives and methods of use thereof |
06/27/2013 | CA2858328A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
06/27/2013 | CA2857257A1 Benzyl sulfonamide derivatives as rorc modulators |
06/26/2013 | EP2606888A1 Trpm8 antagonists |
06/26/2013 | EP2606727A1 Compounds with nematicidal activity |
06/26/2013 | EP2606045A1 Oxadiazole inhibitors of leukotriene production |
06/26/2013 | EP2606044A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
06/26/2013 | EP2606041A2 Compounds and methods for the treatment or prevention of flaviviridae viral infections |
06/26/2013 | EP2606036A1 New compounds |
06/26/2013 | EP2606034A1 Pyrimidine derivatives as fak inhibitors |
06/26/2013 | EP2606020A2 Method of synthesis of substituted hexitols such as dianhydrogalactitol |
06/26/2013 | CN103180316A Compounds that modulate intracellular calciu |
06/26/2013 | CN103180314A Oxadiazole inhibitors of leukotriene production |
06/26/2013 | CN103180312A Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine |
06/26/2013 | CN103180303A 5-trifluoromethyl-4-nitro-2-isoxazoline compounds and preparing process therefor |
06/26/2013 | CN103180296A Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
06/26/2013 | CN103180291A Alkoxyimino derivative and pest control agent |
06/26/2013 | CN103172654A Taxane compound and preparation method thereof |
06/26/2013 | CN103172627A Heterocyclic benzopyrimidine or quinoline compound and applications thereof |
06/26/2013 | CN103172626A Dye compound |
06/26/2013 | CN103172625A Intermediate compound for cabazitaxel |
06/26/2013 | CN103172584A Biisoxazole methyl ether derivative and preparation method thereof |
06/26/2013 | CN102196809B Agent for treatment of diabetic nephropathy |
06/26/2013 | CN101426780B Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
06/25/2013 | US8471019 Quinoid systems as organic semiconductors |
06/25/2013 | US8470854 Lactam-containing compounds and derivatives thereof as factor XA inhibitors |
06/25/2013 | US8470850 Inhibitors of VEGF receptor and HGF receptor signalling |
06/25/2013 | US8470821 PDE4B inhibitors and uses therefor |
06/25/2013 | US8470820 Nitrogen-containing heteroaryl derivatives |
06/25/2013 | US8470819 Benzimidazole and aza-benzimidazole carboxamides |
06/25/2013 | US8470817 Compounds and methods for treatment of cancer |
06/25/2013 | US8470816 Nitrogen-containing heterocyclic compound and use thereof |
06/25/2013 | US8470811 Substituted heterocyclylbenzylpyrazoles and use thereof |
06/25/2013 | US8470810 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
06/25/2013 | US8470782 Transglutaminase inhibitors and methods of use thereof |
06/25/2013 | US8470529 Methine-substituted cyanine dye compounds |
06/25/2013 | CA2725425C Homocysteine synthase inhibitor |
06/25/2013 | CA2591912C Pyrimidinylisoxazole derivatives |
06/25/2013 | CA2570264C 3-aminoindazoles |
06/25/2013 | CA2285241C Substituted 3-cyano quinolines |
06/20/2013 | WO2013090929A1 Amino quinoline derivatives inhibitors of hcv |
06/20/2013 | WO2013090454A2 Novel glp-1 receptor modulators |
06/20/2013 | WO2013089573A1 Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor |
06/20/2013 | WO2013089212A1 Substituted triazine derivative and pharmaceutical composition containing same |
06/20/2013 | WO2013088384A2 Solid state forms of azilsartan and azilsartan medoxomil monopotassium and preparation thereof |
06/20/2013 | WO2013087932A1 Coupler with 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses |
06/20/2013 | WO2013087807A1 4-aryl imidazole derivatives as mglu5 positive allesteric modiulators |
06/20/2013 | WO2013087805A1 Piperazine derivatives and their use as positive allosteric modulators of mglu5 receptors |
06/20/2013 | WO2013087738A1 Novel compounds |
06/20/2013 | WO2013087643A1 1,3,5 -triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof |
06/20/2013 | WO2013087577A1 N-(1,2,5-oxadiazol-3-yl), n-(1,3,4-oxadiazol-2-yl), n-(tetrazol-5-yl), and n-(triazol-5-yl) aryl carboxylic acid amides and use thereof as herbicides |
06/20/2013 | WO2013063458A3 Inhibiting g protein coupled receptor 6 kinase polypeptides |
06/20/2013 | WO2013060744A3 1, 2, 4 - oxadiazole derivatives as ethr inhibitors for use in the treatment tuberculosis |
06/20/2013 | WO2013057739A3 An improved process for preparation of zolmitriptan |
06/20/2013 | WO2013057013A3 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
06/20/2013 | WO2013033268A3 Bivalent bromodomain ligands, and methods of using same |